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Per- and poly-fluoroalkyl substances (PFASs) have been widely used and detected in human 
matrices. Evidence that PFAS exposure may be associated with adverse human reproductive 
health effects exists, however, data is limited. The use of a human matrix such as follicular 
fluid to determine chemical exposure, along with reproductive data will be used to investigate 
if there is a relationship between PFAS exposure and human fertility.  
 
Objective 
This study aims to: (1) assess if associations exist between PFAS concentrations and/or age 
and fertilisation rate (as determined in follicular fluid of women in Australia who received 
assisted reproductive treatment (ART)); and (2) assess if associations exist between PFAS 
concentrations and infertility aetiology.  
 
Methods 
Follicular fluids were originally collected from participants who underwent fully stimulated 
ART treatment cycles at an in vitro fertilisation (IVF) clinic in the period 2006-2009 and 2010-
11 in Queensland, Australia.  The samples were available for analysis of 32 PFASs including 
perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonate 
(PFHxS), and perfluorononanoic acid (PFNA) using high performance liquid chromatography 
tandem mass spectrometry (HPLC-MS/MS). 97 samples were matched with limited 
demographic data (age and fertilisation rate) and five infertility factors (three known female 
factors): 1) endometriosis, 2) polycystic ovarian syndrome (PCOS), and 3) genital tract 
infections - tubal/pelvic inflammation disease; as well as 4) male factor, and 5) idiopathic or 
unknown from either males or females. SPSS was used for linear regression analysis.  
 
Results 
PFASs were detected in all follicular fluid samples with the mean concentrations of PFOS and 
PFOA, 4.9, and 2.4 ng/ml, respectively. A lower fertilisation rate was observed at higher age 
when age was added as a covariate, but there was no relationship between PFAS concentrations 
and fertilisation rate. There were few statistically significant associations between PFAS 
concentrations in follicular fluid and infertility factors. Log-transformed PFHxS concentrations 
were lower in females with endometriosis (factor 1) than in women who had reported ‘male 
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factors’ as a reason of infertility, while PFHpA was higher in women who had infertile due to 
female factors (factor 1-3) compared to those who had infertile due to male factor. 
 
Conclusion: PFASs were detected in follicular fluid of Australian women who had been 
treated at an IVF clinic. PFAS exposure found in follicular fluids is linked to increased risk of 
some infertility factors, and increased age was associated with decreased fertilisation rate in 
our data. But there was no relationship between PFAS and ferlitisation rate. Further large-scale 




Per- and poly-fluoroalkyl substances (PFASs), are chemicals that have been used widely as 
surfactants, lubricants, floor waxes, fire-fighting foams, denture cleaners, shampoos, 
pharmaceutical products, and in food packaging since the 1950s (Kantiani et al., 2010). The 
most common exposure route for PFAS is via ingestion, followed by dermal contact and 
inhalation (Quaak et al., 2016; D’Hollander et al., 2014; Jian et al., 2017).  
 
Studies have shown potential associations between PFAS exposure and adverse health effects 
for metabolism, thyroid function, neurodevelopment, cancers, cardiovascular diseases, 
reproductive functions, and immunity (as reviewed by Kirk et al., 2018). Kirk et al. (2018) 
confirmed that while there are increasing numbers of studies investigating the health effects of 
exposure to PFASs, the results are limited or inconsistent.  When looking specifically in terms 
of reproductive health outcomes, conflicting results have been observed (Fei et al., 2009; Fei 
et al., 2012; Whitworth et al., 2012; Jorgensen et al., 2014; Velez et al., 2015; Vestergaard et 
al., 2012; Buck Louis et al., 2013; Bach et al., 2015; Barrett et al., 2015). For example, lower 
levels of reproductive hormones, such as estradiol and progesterone, were related to higher 
concentrations of perfluorooctane sulfonate (PFOS), and perfluorooctane sulfonamide 
(PFOSA) in nulliparous women (women who have never given birth) (Barrett et al., 2015). 
However, the results were not consistent for other PFASs, including perfluorooctanoic acid 
(PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), 
perfluoroundecanoic acid (PFUnDA) and perfluorohexane sulphonate (PFHxS) in parous 
women (women who have given birth) (Barrett et al., 2015). Fei et al. (2009; 2012) found lower 
fecundability (ability to achieve pregnancy), when comparing higher PFOS (26.1-43.2 ng/mL) 
to lower PFOS exposure (<26.1 ng/mL), when stratified by parity. There was an association 
between PFOS exposure and increased odds of infertility in three higher quartiles of PFOS 
concentrations when compared with the lowest quartile (Fei et al., 2009). No association was 
found between PFOS exposure and subfecundability or infertility (Velez et al., 2015; Bach et 
al., 2015).   
 
PFASs are known as possible endocrine disrupting chemicals (EDCs) with adverse health 
effects on the endocrine system (Stahl et al., 2011; Caserta et al., 2013; DeWitt 2015). For 
example, the pituitary gland produces fertility hormones, including follicle stimulating 
hormones and luteinizing hormone, which are vital for ovulation and successful conception. 
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(Stach et al., 2011). Interference by PFASs or other chemicals on the endocrine system may 
cause reproductive health issues, such as infertility or hormone imbalance in women (Caserta 
et al., 2013; DeWitt 2015; Kim et al., 2019).  
 
PFASs are persistent and bioaccumulate with concentrations detected in human samples 
worldwide (Cho et al., 2015 (South Korea); Stubleski et al., 2016 (Sweden); Whitworth et al., 
2012 (Norway); Olsen et al., 2017 (USA); Gao et al., 2019 (China)). In Australia, PFAS were 
detected in human serum samples dating back to 2002 with levels similar to or higher than in 
European and Asian countries (Toms et al., 2014). There is recent interest in Australia and 
worldwide as to whether or not PFAS exposure may be linked to adverse health effects 
specifically in communities with PFAS exposure through drinking water and in occupationally 
exposed groups such as firefighters (Rotander et al., 2015). 
  
Infertility, defined as the inability to conceive after one year of unprotected intercourse, is a 
global public health issue affecting about 15% of the population (Datta et al., 2016). Female 
fertility rate, defined as the average number of children born to a woman during her 
reproductive years, is likely to decrease with increasing age, and/ or an underlying medical 
condition that might affect ovulation or hormone imbalance, or cause blocked fallopian tubes 
(Barbieri 2018; Jaward et al., 2018). The most common medical conditions experienced by 
infertile women are endometriosis, polycystic ovarian syndrome, or pelvic inflammatory 
disease while poor semen quality is considered the main male cause (Hruska et al., 2000; Piotr 
et al., 2016; Skakkebaek et al., 2016; Sifakis et al., 2017; Barbieri 2018). 
  
Human exposure to PFAS can be measured by analysis of food/drinking water, and through 
analysis of human matrices, such as blood serum, urine or breast milk.  In this study, PFASs 
were examined in follicular fluid.  This is a liquid in the ovarian follicle, which can be collected 
when a woman undergoes egg harvest during assisted reproductive technology (ART) 
treatment. Studies have used follicular fluid to measure PFASs, likely due to ease of collection, 
which is relatively non-invasive if carried out opportunistically (Governini et al., 2011; McCoy 
et al., 2017; Petro et al., 2014; Heffernan et al., 2018). Despite the determination of PFASs in 
follicular fluid, current data is limited to conclude whether associations exist between PFAS 




Therefore, this study aims to assess if associations exist between: (1) PFAS concentrations 
and/or age and fertilisation rate (as determined in follicular fluid of women in Australia who 
received ART); and (2) PFAS concentrations and infertility aetiology.  
 
 
2. Materials and Methods 
2.1. Sample collection 
Follicular fluid samples were collected from female participants who underwent fully 
stimulated ART treatment cycles at an IVF (in vitro fertilisation) clinic in Queensland in the 
period 2006-2009 and 2010-2011 (as part of the “Asymptomatic upper genital tract infections 
in infertile couples and assisted reproductive technology outcomes (ART)” and “Prevalent 
microorganisms detected in the female upper genital tract: the effect of these microorganisms 
on oocytes and on assisted reproductive technology outcomes” projects (Pelzer et al., 2013)). 
The samples were obtained when the participants were undergoing egg harvest for IVF as 
described previously (Pelzer et al., 2013). The data available included date of birth, infertility 
aetiology, fertilisation rate, and past clinical history of infertility. Study participants had been 
classified into groups depending on the aetiology of infertility for the couples including: three 
female factors with 1= endometriosis, 2= polycystic ovarian syndrome (PCOS), 3= genital tract 
infections (tubal/pelvic inflammation disease); 4= male factor (this is infertility due to only 
male partners issues, but detailed health information was not given); and 5= idiopathic or 
unknown. Factor 5, idiopathic, means causes of infertility were not identified from either the 
female or the male. We considered infertility aetiology 1, 2, and 3 as female case groups, and 
infertility aetiology factor 4 as a control group. Whilst factor 5 was included in the analysis it 
was not included as either a case group or a control group due to its unknown causes. ART 
treatment cycle(s) outcomes were also recorded for each couple. It should be noted that the 
date of sample collection was not supplied, only that the samples were collected between 2006 
and 2010. In order to calculate an age at date of collection, we have taken a mid-point of 2008 
and used participant date of birth to calculate an approximate age.  
 
2.2 Ethics statement 
We sought and received a waiver of consent to use follicular samples for analysis of PFAS 
from the Queensland University of Technology (QUT) ethics committee (approval number: 
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1800000016) and The University of Queensland Human Research Ethic Committee (approval 
number: 2018000550).  
 
2.3 Chemical Analysis for PFASs 
Analysis of the follicular fluid samples was undertaken at the Queensland Alliance for 
Environmental Health Sciences (QAEHS), The University of Queensland. Samples were 
analyzed for 32 PFASs; perfluorobutanoic acid (PFBA), perfluoropetanoic acid (PFPeA), 
perfluorohexanoic acid (PFHxA), perfluorohepatanoic acid (PFHpA), perfluorooctanoic acid 
(PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), 
perfluoroundecanoic acid (PFUnDA), perfluorododecanoic acid (PFDoDA), 
perfluorotridecanoic acid (PFTrDA), perfluorotetradecanoic acid (PFTeDA), 
perfluorohexadecanoic acid (PFHxDA), perfluorooctadecanoic acid (PFODA), 
perfluorobutane sulphonate (PFBS), perfluoropentane sulphonate (PFPeS), perfluorohexane 
sulphonate (PFHxS), perfluoroheptane sulphonate (PFHpS), perfluorooctane sulfonate (PFOS), 
perfluorononane sulfonate (PFNS), perfluordecane sulphonate (PFDS), perfluordodecane 
sulphonate (PFDoDS), sodium 1H,1H,2H,2H-perfluorohexane sulfonate (4:2) (8:2 FTS), 
sodium 1H,1H,2H,2H-perfluorohexane sulfonate (4:2) (4:2 FTS), Sodium 1H,1H,2H,2H-
perfluorooctane sulfonate (6:2) (6:2 FTS), sodium 1H,1H,2H,2H-perfluorodecane sulfonate 
(8:2) (8:2 FTS), perfluoroethylcyclohexane sulfonate (PFECHS), perfluoro-1-octane 
sulfonamide (FOSA), n-ethylperfluoro-1-octane sulfonamidoacetic acid (NEtFOSAA), n-
methylperfluoro-1-octane sulfonamidoacetic acid (NMeFOSAA), n-methylperfluoro-1-octane 
sulfonamide (NMeFOSA), n-ethylperfluoro-1-octane sulfonamide (NEtFOSA), 2-(N-
methylperfluoro-1-octane sulfonamido)-ethanol (NMe FOSE), 2-(N-ethylperfluoro-1-octane 
sulfonamido)-ethanol (NEt FOSE) (Supplementary information Table S1). A 200 μl aliquot of 
follicular fluid was transferred to a 2 ml Eppendorf tube, followed by addition of the internal 
standards. Proteins were precipitated with acetonitrile, centrifuged, filtered (2 μm GHP 
membrane; Pall, East Hills, NY, USA), and concentrated to 200µl under a gentle stream of 
nitrogen. Samples were reconstituted to 500µl with 5 mM ammonium acetate in water and 
spiked with recovery standards prior to analysis via high performance liquid chromatography 
tandem mass spectrometry (HPLC-MS/MS) using a Nexera HPLC (Shimadzu Corp., Kyoto, 
Japan) coupled to a Triple Quad 6500+ mass spectrometer (Sciex, Melbourne, Australia) with 
electrospray ionization (ESI) interface operating in negative mode. Chromatographic 
separation of the analytes was achieved with a Gemini C18 column (50 x 2.0 mm, 4 μm; 
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Phenomenex, Torrance, CA), maintained at 45°C, with a flow rate of 0.3 mL/min and injection 
volume of 5 μL. Mobile phases consisted of methanol water (1:99, v/v) (A), and methanol: 
water (95:5, v/v) (B), with 5mM ammonium acetate in both phases. An isolator column 
(Phenomenex) was included inline directly after the mobile phase mixing chamber to delay 
elution of solvent-derived background PFASs contamination. Data acquisition and processing 
was carried out using analyst® TF 1.6 and MultiQuantTM software (Sciex). If the PFASs were 
detected in less than 60% of samples, they were excluded from statistical analysis (eg: PFBA, 




Laboratory blanks (MilliQ water) were extracted and analyzed in parallel with each batch of 
samples. Batches included inter-batch replicates which generally showed CV < 15%. The 
method limit of quantification (LOQ) was calculated by multiplying the SD obtained from 
injecting the lowest calibration standard seven times by 10. Percentage average recovery 
ranged from 70 to 110%. 
 
2.4 Data analysis 
Descriptive statistics were calculated to summarize overall cohort characteristics and PFAS 
concentrations in follicular fluid samples. Evidence of associations between PFAS 
concentrations and fertility variables were evaluated using linear modelling. A linear regression 
model was fitted to examine the influence of PFAS concentrations and age on expected 
fertilisation rates, which was defined as number of oocytes fertilized by ART. This model 
specified fertilisation rate as the dependent variable, with participant age (added as a covariate) 
and individual PFAS concentrations included as continuous independent variables. To assess 
whether PFAS concentrations varied by aetiology infertility factors, a one-way analysis of 
variance (ANOVA) was fitted, with log-transformed concentrations as the dependent variable, 
and aetiology factor as a categorical independent variable. Our decision to apply a log 
transformation was informed by findings of preliminary analysis to satisfy residual 
assumptions. Linear modelling outcomes were summarized by parameter estimates and 
corresponding 95% confidence intervals. Hypothesis testing of estimates was conducted to 
determine if associations were statistically significant, assuming a significance level of 0.05. 






The mean age of female participants was 35.4 years, and the mean fertilisation rate was 63% 
(Table 1). Most common aetiology factors of females participating in ART treatment in this 
study was ‘idiopathic (24.7%)’, and male partner’s factors of infertility (22.7%)’ (Table 1). In 
total, 97 follicular samples matched with demographic information were analysed for 32 
PFASs. 8 PFASs were detected in most samples (PFOS, PFOA, PFHxS, PFNA, PFDA, PFHpS, 
PFUnDA, and PFHpA) and were included in further analysis. The concentrations from highest 
to lowest were:  PFOS (Mean  = 4.8; Range = 0.7-22.4 ng/ml), PFOA (2.4; 0.3-14.5 ng/ml), 
PFHxS (1.7; 0.2-21.3 ng/ml),  PFNA (0.5; 0.08-2.0 ng/ml), PFDA (0.2; 0.05-0.9 ng/ml), 
PFHpS (0.1; 0.05-1.1 ng/ml), PFUnDA (0.1;  <LOD-0.4 ng/ml), and PFHpA (0.01; <LOD-0.6 
ng/ml) (Table 2). The remaining 24 PFASs were detected in a small number of samples or at 
<LOD), thus they were not discussed further, details are available in the SI.   
 
 
Table 1. Characteristics and fertility outcomes of participating women for ART (N=97)  
Variable Mean (SD); Range 
Age (years) 35 (4); 23 - 42 
Fertilisation rate (%) 63 (22); 20-100 
Aetiology of infertility  n (%) of 97 participants  
Endometriosis (factor 1) 18 (18.6) 
Polycystic ovarian syndrome (factor 2) 18 (18.6) 
Genital tract infections (factor 3) 15 (15.5) 
Male factors of infertility (factor 4) 22 (22.7) 
Idiopathic (factor 5) 24 (24.7) 








Table 2. Descriptive data of 8 PFASs in follicular fluids (97 demographic information 
matched samples) 
LOD: Limit of detection 
 
3.1.  PFAS concentrations, and fertilisation rate and age  
Fertilisation rate is defined as the number of oocytes fertilized by ART divided by the total 
number of oocytes collected. Information was available for 92 samples (5 missing data points).  
It was found that for every increase of one standard deviation in age, fertilisation rate decreased 
by 1.49 (Estimate= -1.49, 95%CI; -2.64-0.35, p= 0.013). Inconsistent results were observed in 
the relationship between fertilisation rate, age and PFAS concentrations. The concentration of 
selected PFASs in follicular fluid was positively (eg; PFHpA, PFOA, PFUnDA) or negatively 
(eg; PFDA, PFHpS) associated with fertilisation rate, however high levels of uncertainty in 
parameter estimates meant that none of these associations were statistically significant (Table 
3).  
 
Table 3. Associations between PFAS concentrations and fertilisation rate and age CI: 
Confidence interval 
Variables Estimate  95% CI  Test statistic p-value 
Age -1.49  -2.64—0.35 -2.609 0.013 
PFOS 2.279 -0.556-5.114 1.599 0.114 









Mean      S.D 
 
PFOS  98 0.7 22.4 4.8 3.1 
PFHxS  98 0.2 21.3 1.7 2.7 
PFHpS  96 0.05 1.1 0.1 0.1 
PFOA  98 0.3 14.5 2.4 1.7 
PFNA  97 0.08 2.0 0.5 0.3 
PFDA  98 0.05 0.9 0.2 < LOD 
PFHpA  90 < LOD 0.6 0.01 0.008 
PFUnDA  97 < LOD 0.4 0.1 0.007 
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PFHpS  -48.371 -111.980-
15.238 
-1.512 0.134 
PFOA  0.706 -2.219-3.631 0.480 0.633 
PFNA 15.647 -18.849-50.143 0.902 0.370 
PFDA  -60.830 -129.250-7.590 -1.768 0.081 
PFHpA  17.390 -65.276-
100.055 
0.418 0.677 
PFUnDA  73.581 -3.413-150.574 1.900 0.061 
 
 
3.2. PFAS concentrations and infertility by aetiology factors 
Analysis of PFAS concentrations by aetiology factor provided mixed results, with statistically 
significant differences observed for PFHpA (test statistic = 2.4; p-value = 0.04) and PFHxS 
(test statistic = 4.7; p-value = 0.002) (Table 4). For PFHxS, average log transformed 
concentrations were seen to be lowest for aetiology factor 1 (Mean = -0.3; SE = 0.1) and highest 
for aetiology factor 2 (Mean = 0.3; SE = 0.1). For PFHpA, average concentrations were 
observed to be lowest for aetiology factor 4 (Mean =-1.5; SE = 0.1) and highest for aetiology 
factor both 3, and 5 (Mean = -1.2; SE = 0.1). When female aetiology factors of infertility 
(factors 1-3) were compared to male factor of infertility (factor 4), the concentrations of PFHpA 
were lower in the male infertility factor than the female infertility factors, and the 
concentrations of PFHxS were lower in only the female infertility factor of endometriosis 
(Table 4).  
 
Table 4. Association between PFAS concentrations and infertility by 5 aetiology factors. 








































PFOS  0.6 (0.04) 0.7 (0.1) 0.5 (0.04) 0.6 (0.03) 0.5 (0.06) 2.8 
(0.26) 




-0.02 (0.1) 4.7 
(0.002) 




-0.9 (0.05) 3.12 
(0.15) 
PFOA  0.3 (0.1) 0.4 (0.1) 0.2 (0.1) 0.3 (0.03) 0.3 (0.04) 1.7 
(0.15) 
PFNA  -0.3 (0.1) -0.3 (0.1) -0.3 (0.1) -0.3 
(0.02) 
-0.3 (0.02) 0.21 
(0.93) 
PFDA  -0.7 (0.1) -0.8 (0.1) -0.6 (0.1) -0.7 
(0.03) 
-0.7 (0.04) 0.11 
(0.97) 
PFHpA  -1.4 (0.1) -1.3 (0.1) -1.2 (0.1) -1.5 (0.1) -1.2 (0.1) 2.4 
(0.04) 
PFUnDA  -1.04 (0.7) -0.9 (0.1) -0.9 (0.1) -0.9 
(0.03) 




4. Discussion  
In this study, PFASs were detected in follicular fluid in women experiencing infertility. We 
observed association between PFAS, such as PFHpA, or PFHxS, and the 5 aetiology factors of 
infertility. From the limited studies investigating follicular fluid and fertility effects, McCoy et 
al. (2017) found no significant associations between ovarian response measures and PFAS 
concentrations, and also found decreased blastocyst conversion rate in follicular fluid exposed 
to perflurononanoic acid (PFNA), and perfluorodecanoic acid (PFDA). Heffernan et al. (2018) 
conducted a study using serum and follicular fluid of women with and without polycystic 
ovarian syndrome (PCOS) undergoing fertility treatment and found higher serum PFOS 
concentrations in PCOS cases than controls, and in women with irregular menstrual cycles 
compared to women with regular menstrual cycles. Governini et al. (2011) reported that PFASs 
were present in human follicular fluid and suggested PFAS concentrations had a potentially 
detrimental effect on oocyte fertilisation capacity but the sample size was limited (n=16). 
13 
 
Higher levels of PFNA have also been associated with increased risk of infertility in women 
(Jorgensen et al., 2014). While in another study, the presence of higher PFASs in human 
follicular fluid (a linear combination of PFOA, PFOS, PFNS and PFHxS) had a higher chance 
of an oocyte developing into a high-quality embryo (Petro et al., 2014). 
 
Associations were found between PFHxS, and PFHpA, and 5 aetiology factors of infertility. 
Epidemiological studies have reported an association between PFASs, and infertility caused by 
endometriosis (Vagi et al., 2014; Campbell et al., 216; Wang et al., 2017). In Chinese females 
seeking ART treatment due to endometriosis, plasma levels of perfluorobutane sulfonic acid 
(PFBS), which were excluded in this current study due to low detection rate, was related to an 
increased risk of infertility (Wang et al., 2017). In the United States of America, women with 
endometriosis had higher levels of PFNA, PFOA and PFOS (Campbell et al., 2016). There was 
also evidence of a relationship between PCOS and PFASs exposure. Vagi et al (2014) reported 
higher serum levels of PFOA and PFOS in females with PCOS compared to females with no 
PCOS. Although incidence of genital tract infections in both females and males is related to 
risk of infertility, the effects of PFAS exposure on genital tract infections have not been well 
understood (Pellati et al., 2008). Further epidemiology studies are needed to identify if these 
disease-causing infertilities are associated with PFAS exposure.  
 
 
In the current study, we used individual samples of follicular fluid, and were therefore able to 
measure the range of PFAS concentrations (minimum to maximum) from individual persons. 
This is advantageous as the body of exposure data on PFAS in Australia uses pooled blood 
serum data which has the limitation of not being able to identify extreme concentrations, but 
rather provides a mean of the concentrations of the individuals in that pool (Toms et al. 2019).  
Individual’s serum samples have been analysed for PFASs in pregnant women from Western 
Australia (Callan et al., 2016), community residents (Bräunig et al., 2017), and workers 
exposed to PFASs (Rotander et al., 2015) in Australia. In the current study, we were able to 
calculate the inter quartile range (IQR) for PFASs in Australia which showed little variation in 
concentrations among the 97 women. This little variation was also observed in 98 pregnant 
women in the Western Australian study by Callen et al. (2016) (PFOS 0.45-8.1 ng/L, PFHxS 
0.06-3.3 ng/L, PFOA 0.21-3.1 ng/L).  PFOS, PFOA, and PFHxS were detected at the highest 
concentrations in the follicular fluid as has been seen in human serum in Australia (Toms et al., 
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2009). This finding is consistent with follicular fluid studies from Belgium (Petro et al., 2014), 
the United States of America (McCoy et al., 2017), and the United Kingdom (Heffernan et al., 
2018). 
 
In terms of age effects on PFASs, there were no trends in any of the PFAS concentrations by 
age. As is expected from samples from females of child-bearing age, the age range is 
reasonably narrow making the assessment of trends difficult.  Age trends have been identified 
in previous studies of Australian serum covering the full lifecycle where different PFAS 
concentrations varied with age (Toms et al., 2019).  We found decreased fertilisation rate in 
follicular fluids is related to increased age, confirming accepted evidence that fertilisation rate 




Limited demographic information available on participants and a small sample size limited the 
interpretation of this dataset. Another limitation arose from simplifying causes of infertility to 
five infertility aetiology factors, as human infertility is influenced by various factors, not only 




In conclusion, we identified PFAS in follicular fluid of Australian women who had been treated 
at an IVF clinic. PFOS, PFOA, and PFHxS were detected in the highest concentrations in the 
follicular fluids. Increased age was associated with decreased fertilisation rate in our data. 
There were significant differences in PFAS concentrations between female infertility factors 
and the control group that showed links between PFAS exposures and increased risk of 
infertility factors. Further studies are needed to investigate the relationship between PFAS 
levels and health effects including human infertility.  
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